HIPRA is a European multinational pharmaceutical company focused on prevention and diagnosis for human and animal health, with a wide range of innovative vaccines and advanced diagnostic services. Research is of paramount importance at HIPRA. Over the past 10 years, 22 innovative vaccines have been launched and HIPRA has set the tone in the development of vaccination technology. The company spends 10% of its annual turnover on R&D activities. In the field of vaccine production, HIPRA is one of the world's top pharmaceutical companies for the veterinary sector due to its years of knowledge and experience.
